LOMBARDI, ZOE
 Distribuzione geografica
Continente #
EU - Europa 246
NA - Nord America 110
AS - Asia 56
AF - Africa 1
Totale 413
Nazione #
US - Stati Uniti d'America 108
RU - Federazione Russa 92
IT - Italia 58
PL - Polonia 48
CN - Cina 20
IE - Irlanda 18
SG - Singapore 12
DE - Germania 11
SE - Svezia 9
HK - Hong Kong 7
JO - Giordania 5
FI - Finlandia 4
VN - Vietnam 4
GB - Regno Unito 3
ID - Indonesia 3
IN - India 3
CA - Canada 2
CH - Svizzera 2
TW - Taiwan 2
CI - Costa d'Avorio 1
FR - Francia 1
Totale 413
Città #
Warsaw 48
Florence 26
Chandler 17
Santa Clara 17
Dublin 16
Singapore 10
Moscow 9
Woodbridge 9
Altamura 6
Ashburn 6
Fairfield 6
Hong Kong 6
Lawrence 6
Munich 6
Turin 6
Houston 5
Rome 5
Seattle 5
Cambridge 4
Dong Ket 4
Boston 3
London 3
Malang 3
Princeton 3
Shanghai 3
Bern 2
Boardman 2
Buffalo 2
Guangzhou 2
Helsinki 2
Kaohsiung City 2
Karlskrona 2
Lappeenranta 2
Milan 2
Mumbai 2
Nuremberg 2
Rubano 2
Toronto 2
Wilmington 2
Zhengzhou 2
Abidjan 1
Andover 1
Ann Arbor 1
Castel Volturno 1
Castelliri 1
Gallatin 1
Gunzenhausen 1
Heidelberg 1
Livorno 1
Los Angeles 1
Norwalk 1
Pune 1
San Diego 1
Totale 275
Nome #
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 151
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 122
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 80
Importin subunit beta‐1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation 40
Latent-transforming growth factor β-binding protein 1/Transforming growth factor β1 complex drives antitumoral effects upon ERK5 targeting in melanoma 38
Totale 431
Categoria #
all - tutte 1.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 2 0 3 4 3
2020/202171 3 6 0 18 4 6 4 8 6 12 0 4
2021/202236 9 0 0 2 7 0 1 4 3 2 2 6
2022/202387 6 18 4 1 5 13 14 2 10 4 2 8
2023/202467 3 2 2 6 3 7 2 14 4 4 15 5
2024/2025158 26 40 24 54 14 0 0 0 0 0 0 0
Totale 431